Decrease in Visual Acuity as the Initial Clinical Presentation of Lung Adenocarcinoma: A Case Report

Authors : Musallam Mohammeda; OuiameNabou; Soufiane Afkir; Manal Chafik; Rachid Sekhsoukh; Afafe Thouil, Hatim Kouismi

Volume/Issue : Volume 7 - 2022, Issue 5 - May

Google Scholar :

Scribd :


Primary lung cancer is the leading cause of choroidal metastasis for men, but its revelation by the latter is rare. Case presentation:- The reported observation treats the case of a 50-year-old man who smoked twenty-four packyears, with no particular pathological history, who initially consulted for a rapidly progressive decline in the visual acuity of the left eye. The ophthalmic exam and the explorations concluded to the diagnosis of choroidal metastasis of a primary bronchial adenocarcinoma, which was confirmed by the bronchial biopsy. Clinical discussion:- It is the decline in visual acuity that motivated our patient to consult, which is usually rare since choroidal metastases are often asymptomatic. The diagnosis of choroidal metastasis is usually based on bundle of clinical and radiological arguments. Retinal angiography, ocular ultrasound and MRI visualize nonspecific retinal lesions. The aim of the treatment in choroidal metastases is to preserve visual function. Local radiotherapy has proven its effectiveness and allows regression of symptoms. Conclusion: Before every choroidal metastasis, the search for primary lung cancer must be systematic. The main therapeutic modalities include systemic and local treatments. Currently, the feasibility and effectiveness of various treatment options are controversial around the world.

Keywords : Metastasis, Choroid, lung cancer, adenocarcinoma, radiotherapy


Paper Submission Last Date
31 - March - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.